Impact Global Health

R&D

The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.

News

Telehealth firm Hims & Hers will soon start selling some unapproved peptides subject to the FDA's enforcement discretion policy announced last month.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.